SOX11 and glioma: The transcription factor SOX11 has recently been identified as a diagnostic, prognostic and/or functional antigen in a variety of cancers including mantle cell lymphoma (MCL)[1-6], epithelial ovarian cancer (EOC)[7,8] and gliomas[9].